Skip to Main Content

Paper Details

Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter Study.
Eur Urol
65
2021
Author NameAffiliation
Eric WinquistWestern University
  • 1 - 1

Datasets

Release 1.2